Helicobacter pylori eradication therapy is not associated with increased risk of cardiovascular mortality, based on a national cohort study

Gastro Hep Adv. 2022;1(1):25-28. doi: 10.1016/j.gastha.2021.10.003. Epub 2022 Feb 7.

Shailja C Shah^{1

2}, Sunish Shah^{3

4}, Alese E Halvorson⁵, Adriana Hung^{6

7}, Robert A Greevy Jr^{5

6}, Christianne L Roumie^{6

8

9}

¹ Gastroenterology Section, VA San Diego Healthcare System, San Diego, CA.
² Division of Gastroenterology, University of California, San Diego, San Diego, CA.
³ Antimicrobial Management Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
⁴ Department of Pharmacy Services, Yale New Haven Health System, New Haven, Connecticut, USA.
⁵ Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN.
⁶ VA Tennessee Valley, Clinical Sciences Research and Development.
⁷ Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN.
⁸ Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
⁹ VA Geriatrics Research Education and Clinical Center (GRECC), VA Tennessee Valley Health System, Nashville, TN.

No abstract available

Keywords: antibiotics; arrythmia; drug safety; gastroenterology; kidney disease; sudden cardiac death.

Grants and funding